Five-year follow-up results demonstrate that Cartiva’s Synthetic Cartilage Implant (SCI) provided long-term durability in pain and functional improvements in the treatment of great toe arthritis.
The objective of MOTION, a pivotal, prospective, randomized multicenter study, was to establish non-inferiority of SCI vs. fusion. The trial enrolled 197 patients at 12 centers. In the original MOTION Study, 135 patients received the Cartiva implant. Of these, long-term outcomes were available for 106 patients with a mean follow-up of 5.8 ± 0.7 (range: 4.4 to 8.0) years.
Outcomes demonstrate that Cartiva SCI provides:
Durable pain relief: patients achieved a 97% median reduction in pain
Sustainable functional improvement: patients demonstrated a 176% median improvement in sports activities
Motion preservation: patients experienced a 25% improvement in range of motion from baseline
High patient satisfaction: 93% of patients say they would have the procedure again
Five-year follow-up results demonstrate that Cartiva's Synthetic Cartilage Implant (SCI) provided long-term durability in pain and functional improvements in the treatment of great toe arthritis.
The objective of MOTION, a pivotal, prospective, randomized multicenter study, was to establish non-inferiority of SCI vs. fusion. The trial...
Five-year follow-up results demonstrate that Cartiva’s Synthetic Cartilage Implant (SCI) provided long-term durability in pain and functional improvements in the treatment of great toe arthritis.
The objective of MOTION, a pivotal, prospective, randomized multicenter study, was to establish non-inferiority of SCI vs. fusion. The trial enrolled 197 patients at 12 centers. In the original MOTION Study, 135 patients received the Cartiva implant. Of these, long-term outcomes were available for 106 patients with a mean follow-up of 5.8 ± 0.7 (range: 4.4 to 8.0) years.
Outcomes demonstrate that Cartiva SCI provides:
Durable pain relief: patients achieved a 97% median reduction in pain
Sustainable functional improvement: patients demonstrated a 176% median improvement in sports activities
Motion preservation: patients experienced a 25% improvement in range of motion from baseline
High patient satisfaction: 93% of patients say they would have the procedure again
Copy to clipboard 
